Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial

BACKGROUND: Kidney pain is a common complication in patients with autosomal dominant polycystic kidney disease (ADPKD), and data from the TEMPO 3:4 trial suggested that tolvaptan, a vasopressin V2 receptor antagonist, may have a positive effect on kidney pain in this patient group. Because pain is d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Kidney Dis
Main Authors: Casteleijn, Niek F., Blais, Jaime D., Chapman, Arlene B., Czerwiec, Frank S., Devuyst, Olivier, Higashihara, Eiji, Leliveld, Anna M., Ouyang, John, Perrone, Ronald D., Torres, Vicente E., Gansevoort, Ron T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497700/
https://ncbi.nlm.nih.gov/pubmed/27856088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2016.08.028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados